aTyr Pharma Inc. (LIFE)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.90-0.08 (-2.68%)
At close: 4:00 PM EDT
People also watch:
QGENILMNPKIXRAYNWSA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open2.97
Prev Close2.98
Bid2.76 x 400
Ask3.50 x 500
Day's Range2.82 - 3.09
52wk Range2.48 - 19.67
1y Target EstN/A
Market Cap68.78M
P/E Ratio (ttm)-1.16
BetaN/A
Volume76,383
Avg Vol (3m)247,915
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Associated Press20 days ago

    Atyr Pharma reports 2Q loss

    The San Diego-based company said it had a loss of 65 cents per share. In the final minutes of trading on Wednesday, the company's shares hit $2.98. A year ago, they were trading at $18.13. _____ This story ...

  • PR Newswire20 days ago

    aTyr Pharma Announces Second Quarter 2016 Operating Results

    SAN DIEGO, Aug. 10, 2016 /PRNewswire/ -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe, rare diseases, ...

  • aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016
    Capital Cube3 months ago

    aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016

    Click here to see latest analysisaTyr Pharma, Inc. reports financial results for the quarter ended March 31, 2016.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD -16.09 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.LIFE-US‘s earnings and EBITDA are […] (Read more...) The post aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 appeared first on CapitalCube.